Stock MBRX MOLECULIN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Moleculin Biotech, Inc.

Equities

MBRX

US60855D3098

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
4.63 USD +7.47% Intraday chart for Moleculin Biotech, Inc. -0.43% -64.04%
Apr. 18 Sector Update: Health Care Stocks Ease in Afternoon Trading MT
Apr. 18 Moleculin Biotech Secures Orphan Drug Label For Annamycin in EU MT

Chart calendar Moleculin Biotech, Inc.

09f0152f7776e786edb43731b6.-Q-VQxzdXmuz0gY-EUoCALYlh6I-OXOIa9ahSheCikM.vXv4BSuva16GtDRTJCtOMOJUxPVzThfFNIL1AHzDywCSY6IzbbIEEveqPg~94982c6e3d07ce2a3448e1b6cab23d73

Upcoming events on Moleculin Biotech, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-13 Q2 2024 Earnings Release (Projected)
2024-11-12 Q3 2024 Earnings Release (Projected)
2025-03-19 Q4 2024 Earnings Release (Projected)

Past events on Moleculin Biotech, Inc.

2024-04-07 American Association for Cancer Research Meeting
2024-04-04 04:10 pm MedInvest Biotech & Pharma Investor Conference
2024-03-25 08:30 am Q4 2023 Earnings Call
2024-03-22 04:05 pm Q4 2023 Earnings Release
2024-03-18 12:00 pm Roth Conference
2023-11-13 08:30 am Q3 2023 Earnings Call
2023-11-13 08:00 am Q3 2023 Earnings Release
2023-11-01 CTOS Meeting
2023-10-24 12:00 pm Virtual Investor Ask the CEO Conference
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference
2023-08-11 08:30 am Q2 2023 Earnings Call
2023-08-11 06:45 am Q2 2023 Earnings Release
2023-07-12 03:00 pm Virtual Investor Summer Spotlight Series
2023-06-21 01:30 pm Maxim Group Virtual Healthcare Conference
2023-06-15 10:30 am Annual General Meeting
2023-05-11 08:30 am Q1 2023 Earnings Call
2023-05-11 07:05 am Q1 2023 Earnings Release
2023-04-18 01:30 pm American Association for Cancer Research Meeting - Abstract-4947 / 25
2023-03-23 08:30 am Q4 2022 Earnings Call
2023-03-23 07:10 am Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		-29,5
-23,7
-24.49%
-28,0

EBIT
Million USD		Released
Forecast
Spread 		-17,5
-17,6
0.69%		-19,7
-22,3
11.43%		-23,0
-24,1
4.65%		-30,6
-32,5
5.6%		-29,6
-27,1
-9.43%
-30,7

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-13,4
-14,7
8.87%		-17,4
-20,9
16.76%		-15,9
-18,6
14.74%		-29,0
-31,4
7.55%		-29,8
-25,6
-16.08%
-30,2

Net income
Million USD		Released
Forecast
Spread 		-13,2
-14,4
8.42%		-17,4
-20,8
16.43%		-15,9
-19,0
16.47%		-29,0
-31,0
6.36%		-29,8
-25,6
-16.08%
-30,2

EPS
USD		Released
Forecast
Spread 		-28,8
-31,8
9.43%		-26,4
-31,9
17.37%		-8,85
-10,6
16.9%		-15,1
-16,2
6.77%		-15,1
-13,0
-15.92%
-11,5

Announcement Date19/03/2024/03/2124/03/2222/03/2322/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-5,21
-6,31
17.54%		-7,07
-6,14
-15.19%		-7,43
-7,36
-0.94%		-9,08
-8,03
-13.11%		-7,05
-8,89
20.71%		-8,35
-8,26
-1.16%		-6,41
-8,36
23.34%		-5,95
-7,02
15.33%		-8,92
-6,37
-40.03%
-7,55


-6,83


-7,99


-8,20

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-2,83
-5,57
49.3%		-6,87
-5,81
-18.25%		-6,78
-7,37
8.08%		-8,61
-8,17
-5.34%		-6,77
-9,14
25.92%		-7,92
-8,38
5.57%		-5,98
-8,59
30.43%		-5,61
-6,96
19.35%		-10,3
-6,15
-67.09%
-7,40


-6,70


-7,88


-8,12

Net income
Million USD		Released
Forecast
Spread 		-2,83
-5,95
52.5%		-6,87
-6,10
-12.51%		-6,78
-7,32
7.35%		-8,61
-8,02
-7.42%		-6,77
-8,74
22.56%		-7,92
-8,10
2.3%		-5,98
-8,18
26.91%		-5,61
-6,94
19.14%		-10,3
-6,15
-67.09%
-7,40


-6,70


-7,88


-8,12

EPS
USD		Released
Forecast
Spread 		-1,35
-3,15
57.14%		-3,60
-3,15
-14.29%		-3,60
-3,80
5.26%		-4,50
-4,15
-8.43%		-3,45
-4,55
24.18%		-4,20
-4,25
1.18%		-3,00
-4,10
26.83%		-2,85
-3,35
14.93%		-14,4
-3,05
-372.46%
-3,53


-3,22


-3,16


-2,26

Announcement Date24/03/2211/05/2212/08/2210/11/2222/03/2310/05/2310/08/2313/11/2322/03/24----

Upcoming sector events for Moleculin Biotech, Inc.

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Moleculin Biotech, Inc.

Today INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
Today SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
Today SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
Today DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
Today SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
Today REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MBRX Stock
  4. Calendar Moleculin Biotech, Inc.